BRC News

Researchers at UCL have discovered a network of connections in the brain linked to seizures in people with epilepsy.

Scientists examining the causes of cachexia believe they are now one step closer to understanding the causes behind the condition.

Research supported by the BRC has revealed how air pollution can cause lung cancer in people who have never smoked.

A world-first trial for people living with progressive forms of multiple sclerosis (MS) has begun at UCL and UCLH.

A leading platform for dementia research careers and support has secured £1.1 million in funding for five years.

Research has discovered how some skin cancers stop responding to treatment at the end of life.

An event to mark the launch of a new BRC term looked ahead to the future of research at UCLH and UCL.

UCL has been placed 6th globally for medicine and 1st for education in the world’s most consulted university ranking.

Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, a study led by UCL has found.

Predictive performance of polygenic risk scores is limited, according to a new analysis 

Research from UCLH and the Francis Crick Institute has had an important impact on draft NICE guidance.

Prof Laura Shallcross will lead research to reduce the impact of infections in care homes after being awarded a prestigious NIHR Research Professorship.

A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.

A multi-disciplinary team of researchers, involving several UCLH and UCL clinicians and scientists, has developed a way to monitor the progression of movement disorders using motion capture technology and AI.

A new personalised cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international multicentre trial involving researchers at UCL and UCLH.